Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics
ONE NEW FEATURE of our annual Executive War College every May is a Lab CEO SUMMIT which takes place on the Thursday after the Tuesday-Wednesday event. It attracts a growing number of senior lab executives and pathologists who come to explore the strategic directions of the lab industry and pathology profession. This year’s Lab CEO …
Labs Should Leverage Their “Crown Jewels” Read More »
CEO SUMMARY: Disruptive technologies and the arrival of healthcare E-commerce were two common themes which emerged from this year’s Executive War College on Laboratory and Pathology Management. Consensus by faculty and attendees alike was that every lab organization should have an Internet business strategy, along with an accelerated implementation timetable! DESPITE CONTINUING laboratory consolidation and …
War College Identifies Emerging Lab Trends Read More »
CEO SUMMARY: Although Columbia/HCA will pay the feds $745 million as part of its recent settlement, the facts of “Medicare fraud” are far from convincing. Wall Street Journal analyst Holman W. Jenkins, Jr. makes a strong argument that the government was able to pick on Columbia/HCA for a variety of reasons, most tied to former …
Columbia/HCA’s $745 Mil Settlement Announced Read More »
Expect an announcement this week that Pathology Consultants of America, Inc. (PCA), based in Nashville, Tennessee, has acquired PathSOURCE, Inc. of Port Chester, New York. Both are single specialty physician practice management (PPM) companies devoted exclusively to pathology. Each company has substantial venture capital funding. PathSOURCE, organized by dermatopathologists, did not generate the revenue growth …
“May 30, 2000 Intelligence: Late Breaking Lab News” Read More »
CEO SUMMARY: As healthcare E-commerce rapidly approaches, clinical laboratories will find they have a built-in competitive advantage—their existing business relationship and communication links to physician offices. Bio-Reference Laboratories, Inc. is moving rapidly to capitalize on this competitive advantage. It is making sizable investments to offer physicians more than just laboratory tests. IN THE COMING WORLD …
BRLI Ready To Leverage Physician Relationship Read More »
CEO SUMMARY: Pathology Partners, Inc. got a new President and CEO this month. The company is organized to build and operate independent regional histology and cytology laboratories in support of anatomic pathologists. Its business model is different than competing pathology companies and Pathology Partners believes that it will be well-positioned as integrated clinical care becomes …
New CEO Takes Charge At Pathology Partners Read More »
COLUMBIA/HCA GETS NEW NAME; ACQUIRES FOUR LONDON HOSPITALS NOW THAT IT HAS A SETTLEMENT with the federal government on civil claims of Medicare fraud, expect a rapid cascade of changes at Columbia/HCA Healthcare Corporation, the nation’s largest for-profit hospital company. First is a new name. Effective on May 25, Columbia/HCA is now called HCA-The Healthcare …
Columbia/HCA, AmeriPath, Epitope, STC Technologies, Quest Diagnostics Read More »
OUR FIFTH ANNUAL Executive War College on Lab and Pathology Management is just around the corner. In just a few days, on May 16-17, 400 laboratory executives, administrators and pathologists will gather in New Orleans to learn the latest innovations in the management and operation of laboratories. That makes it timely for this crusty curmudgeon …
Is Your Lab Still Making Buggy Whips? Read More »
There’s another healthcare Ecommerce company starting up. This one’s directed at the clinical laboratory industry. To be called “LabPortal.com,” it’s connected to Golder, Thoma, Cressey, Rauner Inc., Park City Solutions, and American Medical Laboratories. LabPortal.com will be managed by Mark Johnston, who left an executive post at LabCorp to join the new firm. Digene Corporation’s …
“May 8, 2000 Intelligence: Late Breaking Lab News” Read More »
CEO SUMMARY: During the past year, Luminex Corporation moved swiftly to push its LabMAP™ multiplex testing technology into the bioassay marketplace. It found high interest among companies in the pharmaceutical, diagnostics, and bioresearch industries. Luminex executives say that a number of companies are working to have FDA-approved diagnostic test kits available for laboratories by year’s …
Luminex Raises $83 Mil In Public Stock Offering Read More »
The Dark Report • 21806 Briarcliff Dr • Spicewood, TX 78669
Phone: 512-264-7103 • Toll Free Number: 800-560-6363
Email: customerservice@darkintelligencegroup.com
© 2022 The Dark Report. All rights reserved.